HK Stock MarketDetailed Quotes

02373 BEAUTYFARM MED

Watchlist
  • 15.120
  • +0.120+0.80%
Not Open May 31 16:08 CST
3.57BMarket Cap14.99P/E (TTM)

BEAUTYFARM MED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
120.94%288.27M
----
-48.85%130.48M
----
35.31%255.1M
--127.28M
4.88%188.53M
--179.76M
Profit adjustment
Interest (income) - adjustment
---17.54M
----
----
----
----
----
----
---994K
Attributable subsidiary (profit) loss
--51K
----
----
----
----
----
----
----
Impairment and provisions:
132.79%3.44M
--0
-27.92%1.48M
--0
2,730.77%2.05M
---289K
98.25%-78K
---4.45M
-Impairment of property, plant and equipment (reversal)
----
----
----
----
----
----
--862K
----
-Impairmen of inventory (reversal)
99.92%2.65M
----
85.96%1.32M
----
-33.77%712K
---839K
773.98%1.08M
--123K
-Impairment of trade receivables (reversal)
413.55%796K
----
-88.13%155K
----
164.81%1.31M
--550K
55.92%-2.02M
---4.57M
-Other impairments and provisions
----
----
----
----
--34K
----
----
----
Revaluation surplus:
-15.23%-23.85M
--0
11.59%-20.7M
--0
-74.35%-23.41M
---10.84M
-67.48%-13.43M
---8.02M
-Other fair value changes
-15.23%-23.85M
----
11.59%-20.7M
----
-74.35%-23.41M
---10.84M
-67.48%-13.43M
---8.02M
Asset sale loss (gain):
11.26%1.01M
--0
-65.68%906K
--0
-26.09%2.64M
--188K
13.11%3.57M
--3.16M
-Loss (gain) from sale of subsidiary company
----
----
----
----
----
----
-131.00%-310K
--1M
-Loss (gain) on sale of property, machinery and equipment
11.26%1.01M
----
-65.68%906K
----
-31.99%2.64M
--188K
79.89%3.88M
--2.16M
Depreciation and amortization:
11.61%331.74M
--0
8.01%297.24M
--0
6.15%275.19M
--132.92M
15.91%259.25M
--223.66M
-Depreciation
12.27%314.99M
----
6.63%280.57M
----
5.75%263.13M
--126.39M
16.33%248.83M
--213.9M
-Amortization of intangible assets
0.44%16.75M
----
38.26%16.67M
----
15.69%12.06M
--6.53M
6.79%10.42M
--9.76M
Financial expense
0.40%24.81M
----
2.05%24.71M
----
-6.60%24.22M
--12.33M
-8.26%25.93M
--28.26M
Special items
-49.20%10.9M
----
241.13%21.46M
----
-9.99%6.29M
--2.85M
338.94%6.99M
--1.59M
Operating profit before the change of operating capital
35.83%618.83M
--0
-15.96%455.58M
--0
15.15%542.08M
--264.44M
11.30%470.77M
--422.98M
Change of operating capital
Inventory (increase) decrease
-3.42%-47.95M
----
-46.10%-46.36M
----
-381.65%-31.73M
---25.43M
313.43%11.27M
---5.28M
Accounts receivable (increase)decrease
30.07%-24.68M
----
-278.90%-35.3M
----
37.81%-9.32M
---46.8M
-149.66%-14.98M
--30.17M
Accounts payable increase (decrease)
273.80%45.76M
----
-144.46%-26.33M
----
337.21%59.23M
--12.73M
137.07%13.55M
---36.54M
Cash  from business operations
59.79%653.7M
61.73%245.38M
-42.85%409.09M
-46.05%151.73M
-0.19%715.86M
--281.23M
44.69%717.23M
--495.69M
Other taxs
-4.05%-28.19M
-0.13%-23.07M
41.01%-27.09M
12.99%-23.04M
-25.14%-45.93M
---26.48M
-13.34%-36.7M
---32.38M
Special items of business
0.38%61.74M
----
-60.47%61.51M
----
-34.24%155.6M
--76.29M
180.47%236.63M
--84.37M
Net cash from operations
63.75%625.51M
72.75%222.31M
-42.98%382M
-49.49%128.69M
-1.56%669.93M
--254.75M
46.88%680.53M
--463.31M
Cash flow from investment activities
Interest received - investment
--6.06M
----
----
----
----
----
----
----
Loan receivable (increase) decrease
----
----
----
----
----
----
-89.61%6.95M
--66.92M
Decrease in deposits (increase)
-101.71%-241.34M
---383.32M
---119.65M
----
----
----
----
----
Sale of fixed assets
172.60%597K
-98.55%1K
--219K
430.77%69K
----
--13K
--3.18M
----
Purchase of fixed assets
-13.10%-159.24M
4.85%-48.67M
-5.72%-140.79M
-2.60%-51.15M
-97.27%-133.17M
---49.85M
37.39%-67.51M
---107.83M
Sale of subsidiaries
----
----
----
----
118.34%3.66M
----
---19.98M
----
Acquisition of subsidiaries
-83.15%-7.7M
----
62.80%-4.2M
---232K
-104.32%-11.3M
----
---5.53M
----
Recovery of cash from investments
-12.84%1.3B
-37.74%461.29M
8.64%1.49B
1.91%740.9M
74.40%1.37B
--727.05M
82.15%785.53M
--431.26M
Cash on investment
-37.31%-1.61B
-32.15%-682.7M
27.52%-1.17B
32.93%-516.6M
-50.67%-1.61B
---770.26M
-65.60%-1.07B
---647.08M
Net cash from investment operations
-1,426.19%-711.19M
-477.70%-653.4M
113.92%53.63M
285.92%172.99M
-4.45%-385.35M
---93.05M
-43.71%-368.94M
---256.73M
Net cash before financing
-119.67%-85.68M
-242.90%-431.09M
53.07%435.63M
86.57%301.68M
-8.67%284.59M
--161.7M
50.83%311.59M
--206.58M
Cash flow from financing activities
Refund
----
----
----
----
50.00%-6.37M
---6.37M
-7.69%-12.74M
---11.83M
Issuing shares
--506.55M
--506.55M
----
----
----
----
----
----
Interest paid - financing
----
----
----
----
98.46%-17K
---17K
23.40%-1.1M
---1.44M
Dividends paid - financing
57.41%-87M
----
-151.69%-204.26M
-59.67%-122.57M
23.98%-81.16M
---76.76M
-32.35%-106.75M
---80.66M
Absorb investment income
-62.68%4.36M
-86.48%1.58M
--11.68M
--11.68M
----
----
----
--3.49M
Issuance expenses and redemption of securities expenses
-1,115.27%-42.35M
-1,150.60%-34.18M
---3.49M
---2.73M
----
----
----
----
Other items of the financing business
-4.67%-247.81M
30.26%-136.74M
-29.01%-236.76M
-113.97%-196.06M
-20.16%-183.52M
---91.63M
4.41%-152.74M
---159.78M
Net cash from financing operations
130.90%133.74M
208.89%337.21M
-59.67%-432.82M
-77.18%-309.68M
0.83%-271.07M
---174.78M
-9.24%-273.33M
---250.22M
Effect of rate
200.02%12.09M
2,922.57%12.45M
1,691.11%4.03M
346.71%412K
-51.09%225K
---167K
247.44%460K
---312K
Net Cash
1,612.97%48.07M
-1,073.56%-93.89M
-79.25%2.81M
38.84%-8M
-64.66%13.52M
---13.08M
187.66%38.26M
---43.64M
Begining period cash
4.35%164.12M
4.35%164.12M
9.58%157.28M
9.58%157.28M
36.94%143.54M
--143.54M
-29.54%104.82M
--148.77M
Cash at the end
36.65%224.28M
-44.76%82.69M
4.35%164.12M
14.89%149.7M
9.58%157.28M
--130.29M
36.94%143.54M
--104.82M
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
PricewaterhouseCoopers
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax 120.94%288.27M-----48.85%130.48M----35.31%255.1M--127.28M4.88%188.53M--179.76M
Profit adjustment
Interest (income) - adjustment ---17.54M---------------------------994K
Attributable subsidiary (profit) loss --51K----------------------------
Impairment and provisions: 132.79%3.44M--0-27.92%1.48M--02,730.77%2.05M---289K98.25%-78K---4.45M
-Impairment of property, plant and equipment (reversal) --------------------------862K----
-Impairmen of inventory (reversal) 99.92%2.65M----85.96%1.32M-----33.77%712K---839K773.98%1.08M--123K
-Impairment of trade receivables (reversal) 413.55%796K-----88.13%155K----164.81%1.31M--550K55.92%-2.02M---4.57M
-Other impairments and provisions ------------------34K------------
Revaluation surplus: -15.23%-23.85M--011.59%-20.7M--0-74.35%-23.41M---10.84M-67.48%-13.43M---8.02M
-Other fair value changes -15.23%-23.85M----11.59%-20.7M-----74.35%-23.41M---10.84M-67.48%-13.43M---8.02M
Asset sale loss (gain): 11.26%1.01M--0-65.68%906K--0-26.09%2.64M--188K13.11%3.57M--3.16M
-Loss (gain) from sale of subsidiary company -------------------------131.00%-310K--1M
-Loss (gain) on sale of property, machinery and equipment 11.26%1.01M-----65.68%906K-----31.99%2.64M--188K79.89%3.88M--2.16M
Depreciation and amortization: 11.61%331.74M--08.01%297.24M--06.15%275.19M--132.92M15.91%259.25M--223.66M
-Depreciation 12.27%314.99M----6.63%280.57M----5.75%263.13M--126.39M16.33%248.83M--213.9M
-Amortization of intangible assets 0.44%16.75M----38.26%16.67M----15.69%12.06M--6.53M6.79%10.42M--9.76M
Financial expense 0.40%24.81M----2.05%24.71M-----6.60%24.22M--12.33M-8.26%25.93M--28.26M
Special items -49.20%10.9M----241.13%21.46M-----9.99%6.29M--2.85M338.94%6.99M--1.59M
Operating profit before the change of operating capital 35.83%618.83M--0-15.96%455.58M--015.15%542.08M--264.44M11.30%470.77M--422.98M
Change of operating capital
Inventory (increase) decrease -3.42%-47.95M-----46.10%-46.36M-----381.65%-31.73M---25.43M313.43%11.27M---5.28M
Accounts receivable (increase)decrease 30.07%-24.68M-----278.90%-35.3M----37.81%-9.32M---46.8M-149.66%-14.98M--30.17M
Accounts payable increase (decrease) 273.80%45.76M-----144.46%-26.33M----337.21%59.23M--12.73M137.07%13.55M---36.54M
Cash  from business operations 59.79%653.7M61.73%245.38M-42.85%409.09M-46.05%151.73M-0.19%715.86M--281.23M44.69%717.23M--495.69M
Other taxs -4.05%-28.19M-0.13%-23.07M41.01%-27.09M12.99%-23.04M-25.14%-45.93M---26.48M-13.34%-36.7M---32.38M
Special items of business 0.38%61.74M-----60.47%61.51M-----34.24%155.6M--76.29M180.47%236.63M--84.37M
Net cash from operations 63.75%625.51M72.75%222.31M-42.98%382M-49.49%128.69M-1.56%669.93M--254.75M46.88%680.53M--463.31M
Cash flow from investment activities
Interest received - investment --6.06M----------------------------
Loan receivable (increase) decrease -------------------------89.61%6.95M--66.92M
Decrease in deposits (increase) -101.71%-241.34M---383.32M---119.65M--------------------
Sale of fixed assets 172.60%597K-98.55%1K--219K430.77%69K------13K--3.18M----
Purchase of fixed assets -13.10%-159.24M4.85%-48.67M-5.72%-140.79M-2.60%-51.15M-97.27%-133.17M---49.85M37.39%-67.51M---107.83M
Sale of subsidiaries ----------------118.34%3.66M-------19.98M----
Acquisition of subsidiaries -83.15%-7.7M----62.80%-4.2M---232K-104.32%-11.3M-------5.53M----
Recovery of cash from investments -12.84%1.3B-37.74%461.29M8.64%1.49B1.91%740.9M74.40%1.37B--727.05M82.15%785.53M--431.26M
Cash on investment -37.31%-1.61B-32.15%-682.7M27.52%-1.17B32.93%-516.6M-50.67%-1.61B---770.26M-65.60%-1.07B---647.08M
Net cash from investment operations -1,426.19%-711.19M-477.70%-653.4M113.92%53.63M285.92%172.99M-4.45%-385.35M---93.05M-43.71%-368.94M---256.73M
Net cash before financing -119.67%-85.68M-242.90%-431.09M53.07%435.63M86.57%301.68M-8.67%284.59M--161.7M50.83%311.59M--206.58M
Cash flow from financing activities
Refund ----------------50.00%-6.37M---6.37M-7.69%-12.74M---11.83M
Issuing shares --506.55M--506.55M------------------------
Interest paid - financing ----------------98.46%-17K---17K23.40%-1.1M---1.44M
Dividends paid - financing 57.41%-87M-----151.69%-204.26M-59.67%-122.57M23.98%-81.16M---76.76M-32.35%-106.75M---80.66M
Absorb investment income -62.68%4.36M-86.48%1.58M--11.68M--11.68M--------------3.49M
Issuance expenses and redemption of securities expenses -1,115.27%-42.35M-1,150.60%-34.18M---3.49M---2.73M----------------
Other items of the financing business -4.67%-247.81M30.26%-136.74M-29.01%-236.76M-113.97%-196.06M-20.16%-183.52M---91.63M4.41%-152.74M---159.78M
Net cash from financing operations 130.90%133.74M208.89%337.21M-59.67%-432.82M-77.18%-309.68M0.83%-271.07M---174.78M-9.24%-273.33M---250.22M
Effect of rate 200.02%12.09M2,922.57%12.45M1,691.11%4.03M346.71%412K-51.09%225K---167K247.44%460K---312K
Net Cash 1,612.97%48.07M-1,073.56%-93.89M-79.25%2.81M38.84%-8M-64.66%13.52M---13.08M187.66%38.26M---43.64M
Begining period cash 4.35%164.12M4.35%164.12M9.58%157.28M9.58%157.28M36.94%143.54M--143.54M-29.54%104.82M--148.77M
Cash at the end 36.65%224.28M-44.76%82.69M4.35%164.12M14.89%149.7M9.58%157.28M--130.29M36.94%143.54M--104.82M
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopersPricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg